StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies gross margin

Gross margin is gross profit as a percentage of revenue.

AXIM Biotechnologies's gross margin for the twelve months ending Sep 30, 2021 was 100.0%. For fiscal 2019 it was 0.0%, against 95.6% the year before. The highest annual figure on record is 95.6% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 20190.0%−95.6
FY2018Dec 31, 201895.6%+85.7
FY2017Dec 31, 20179.9%+237.4
FY2016Dec 31, 2016-227.5%−225.0
FY2015Dec 31, 2015-2.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 202490.0%−10.0
Q2 FY2023Jun 30, 2023100.0%+0.0
Q3 FY2022Sep 30, 2022100.0%+100.0
Q3 FY2021Sep 30, 2021100.0%+25.7
Q2 FY2021Jun 30, 2021100.0%+0.8
Q1 FY2021Mar 31, 2021100.0%+51.0
Q4 FY2019Dec 31, 20190.0%−72.1
Q1 FY2019Mar 31, 201974.3%−13.7
Q4 FY2018Dec 31, 201899.2%+4.3
Q3 FY2018Sep 30, 201849.0%−34.2
Q2 FY2018Jun 30, 201872.1%+11.8
Q1 FY2018Mar 31, 201888.0%+197.1
Q4 FY2017Dec 31, 201794.8%+921.5
Q3 FY2017Sep 30, 201783.2%+125.5
Q2 FY2017Jun 30, 201760.2%+67.7
Q1 FY2017Mar 31, 2017-109.1%−100.4
Q4 FY2016Dec 31, 2016-826.7%−812.8
Q3 FY2016Sep 30, 2016-42.3%+9.6
Q2 FY2016Jun 30, 2016-7.5%−107.5
Q1 FY2016Mar 31, 2016-8.6%–
Q4 FY2015Dec 31, 2015-13.9%–
Q3 FY2015Sep 30, 2015-51.9%–
Q2 FY2015Jun 30, 2015100.0%–

More AXIM Biotechnologies figures

See a number that looks wrong?